Endoluten
Research OnlyAlso known as: Pineal cytamin, Pineal gland peptides, A-8 pineal peptides
A cytamin-class peptide supplement derived from pineal gland tissue, part of the Russian bioregulator framework. Marketed as an oral supplement for pineal function and melatonin support. Contains peptide complexes rather than defined sequences. No Western clinical validation.
Research Statistics
Minimal Russian-only bioregulator data; pineal peptide with single human study, no replication.
Research Dossier
Overview
What is Endoluten and what does the research say?
Mechanism of Action
Endoluten is a cytamin-class supplement containing peptide complexes derived from pineal gland tissue.
Cytamin Classification
Cytamins are oral supplements in the Russian bioregulator framework:
- Tissue-derived peptide mixtures
- Multiple peptide fractions of varying size
- Marketed as dietary supplements
- Not defined single compounds
Proposed Mechanisms
- Pineal Support - Claimed to support pineal gland function
- Melatonin Regulation - Proposed effects on melatonin synthesis
- Circadian Rhythm - Marketed for sleep and circadian support
Important Limitations
- NOT a defined peptide - contains complex mixture
- Oral peptide bioavailability is generally very low
- No Western clinical validation
- No randomized controlled trials
- Not a substitute for melatonin supplementation
- Not approved by any Western regulatory agency
Evidence-Chained Benefits
Evidence-Chained Benefits
Research findings linked to mechanisms and clinical outcomes
Peptide Interactions
Known and theoretical interactions when combining Endoluten with other peptides. Based on published research and mechanistic considerations.
Epithalon
CompatibleBoth target pineal function - Epithalon is synthetic AEDG tetrapeptide, Endoluten is tissue-derived cytamin. Different administration routes and compositions.
Pinealon
CompatibleBoth target brain/pineal - Pinealon is synthetic tripeptide, Endoluten is tissue-derived complex.
Research Note: Interaction data is based on published literature, mechanistic understanding, and theoretical considerations. Most peptide combinations lack direct clinical study. This information is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare providers.
References
Key Studies Cited
Full reference list available on request. All citations link to PubMed for verification.
Methodology Note
This dossier synthesizes available evidence from peer-reviewed literature, regulatory documents, and clinical trial registries. Evidence strength ratings follow a modified GRADE approach.
For complete methodology details, see our Methodology page.
Important Disclaimer
This dossier is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.
Get Research Alerts
New dossiers and major study summaries delivered to your inbox. Evidence-graded, citation-backed research you can trust.
No spam. Unsubscribe anytime.
Compare Endoluten
Related Peptides
FOXO4-DRI
FOXO4-D-Retro-Inverso, FOXO4-DRI Peptide, Proxofim
A D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction, selectively eliminating senescent cells (senolytic). Preclinical studies in aged mice demonstrated restored fitness, fur density, and renal function. No human clinical trials conducted. More selective than BCL-2 inhibitors but remains unproven in humans.
Glutathione
GSH, L-Glutathione, Reduced Glutathione +1 more
The master antioxidant and most abundant intracellular thiol in mammalian cells. This naturally occurring tripeptide (glutamate-cysteine-glycine) is essential for detoxification, immune function, and cellular protection. Extensively studied with strong mechanistic understanding and growing clinical evidence.
Humanin
HN, HNG, S14G-Humanin +2 more
A 24-amino acid mitochondria-derived peptide (MDP) discovered in 2001 that shows cytoprotective, anti-apoptotic, and neuroprotective effects in preclinical studies. Represents a novel class of signaling molecules encoded within mitochondrial DNA. Extensive academic research with emerging interest in aging, metabolic disease, and neurodegeneration, but no approved clinical applications.
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c, Mitochondrial-derived peptide, MOTS-C peptide
A 16-amino acid mitochondrial-derived peptide encoded in mtDNA that targets AMPK/mTOR pathways for metabolic regulation. Preclinical studies show exercise mimetic and geroprotective effects. Lower MOTS-c levels found in T2D patients. No clinical trials yet conducted in humans.
SHLP-2
Small Humanin-Like Peptide 2, SHLP2, Mitochondrial-Derived Peptide 2
A 26-amino acid mitochondria-derived peptide (MDP) discovered in 2016 from the same mitochondrial DNA region as humanin. Shows cytoprotective, metabolic, and potential longevity effects in preclinical studies. Part of an emerging class of mitochondrial signaling molecules, but human therapeutic data is lacking.
SHLP-6
Small Humanin-Like Peptide 6, SHLP6, Mitochondrial-Derived Peptide 6
A 22-amino acid mitochondria-derived peptide with the unique property of being pro-apoptotic—the opposite of its sister peptides humanin and SHLP-2. Discovered in 2016, SHLP-6 may have applications in cancer and senescent cell clearance. Research is very early-stage with minimal published data.